Resources

11 Resources for

biotechnology company

Subscribe to this listing via:
RSS
Email

BNET Resources

CAMBRIDGE ANTIBODY TECHNOLOGY (CAT).: 678p - Pharmaceuticals - Cambridge Antibody Technology CAT stands out among the UK's biotechnology companies for one big reason: it is the first British biotech company to have a blockbuster product on the market. Humira, the company's antibody dru 678p - Pharmaceuticals - Cambridge Antibody Technology...; Tags: Abbott Laboratories Inc., biotechnology, biotechnology company; Research articles 2006-02-24
Protesters undermine French GM research.(biotechnology company Monsanto have condemned the destruction of two experimental maize plots)(Brief article): A French farmers' union and the biotechnology company Monsanto have condemned the destruction of two experimental maize plots in central France and another in eastern France last Sunday night, Terre-Net reports. A French farmers' union and the biotechnology company Monsanto have condemned the...; Tags: biotechnology, biotechnology company, General Motors Corp., Monsanto; Research articles 2006-08-18
Biotech Companies Question FDA Regulation Proposals.(Knight Ridder/Tribune Business News): Jan. 31--Biotechnology companies planning to conduct gene therapy and animal-to-human transplants are questioning new regulations that require them to provide more details about their tests and immediate public notification of side effects. Jan. 31--Biotechnology companies planning to conduct gene therapy and animal-to-human transplants...; Tags: biotechnology, Biotechnology company, FDA; Research articles 2001-01-30
Local biotech firms flower during May.(securities, finance)(Brief Article): Local biotech companies got a lift during May as investors rewarded signs of progress in new products. After it announced its second consecutive profitable quarter and a medical journal endorsed a product it makes for breast cancer treatment, Down Local biotech companies got...; Tags: biotechnology, biotechnology company, finance, Molex Inc., security, stock; Research articles 2001-06-11
Can You Capture & Value The Price Of Speed?: Outsourcing For Drug Development & Manufacturing: Outsourcing drug research has become more popular, not only because of increased efficiencies in third-party core competencies, but also because numerous Pharmaceutical & Biotech companies are often challenged with conflicting budgets, dated equipment, software or knowledge that may or may not fall short of existing regulatory allowances. Emphasis has traditionally...; Tags: Biotechnology Company, Pharmaceutical Company, Outsourcing, Manufacturing, Biotechnology; White papers 2003-01-01

WuXi PharmaTech Q3 2007 Earnings Call Transcript: Question-and-Answer SessionOperator Your first question comes from Jinsong Du - Credit Suisse. Jinsong Du - Credit Suisse Congratulations on the results. You mentioned in the slides that you now have 80 clients. I remember during the IPO road show that it was at 70. I understand...; Tags: Biotechnology, Biotechnology Company, Call Transcript, Credit Suisse Group AG, Customer, Earnings, General Electric Co., J.P. Morgan Chase & Co., Manufacturing, Seeking Alpha; Earnings calls 2007-11-13
How To Value A Biotechnology Company: The major risk to be quantified in the valuation of a biotechnology company is the risk of successfully completing clinical trials. In order to accurately asses the value of a biotech company, it is crucial to have an understanding of the clinical development process for human therapeutics - the costs,...; Tags: Risk, Deloitte LLP, Biotechnology Company, Clinical Trial, Biotechnology, Healthcare, Strategy, Management; White papers 2009-01-01
Verity PharmaCI: Using Information to Stay Ahead of the Competition in Life Sciences: Pharmaceutical and biotechnology companies are under pressure to bring drugs to market quicker. Thus there is a need to maximize their return on each new drug introduced to the market, to comply with stringent government regulations, to understand the impact of patent expiration on their drug portfolio and to rapidly...; Tags: Verity Inc., Biotechnology Company, Pharmaceutical Company, Life Science, Biotechnology; White papers 2005-06-29
The Drug Industry's Alliance Archipelago: Big pharmaceuticals have the money to fund the development and marketing of new drugs, but their R&D hit rate has not been sufficient to replace products coming off patent. Small biotechnology companies are awash in new technologies, but lack the cash to bring products through the expensive regulatory approval processes....; Tags: Accenture Ltd., Alliance, Biotechnology, Biotechnology Company, Pharmaceutical Company; White papers 2003-12-01
A New Approach to Valuing Biotech Stocks: Stocks of biotechnology companies are soaring. However, while these companies have promising technologies, they are years away from profits. The boomlet shows, however, how hard it is to value biotech stocks. Analysts often use proxy drivers such as the number of patents or the dollar value of partnerships to value...; Tags: University Of Pennsylvania, Biotechnology Company, Biotechnology; White papers 2001-02-11
Sequenom Misses, but Who Cares?: Trader Mark submits: Near term results for Sequenom SQNM are really a moot point as we're looking to mid 2009 forward on this story; the main issue in this new and not so improved environment is making sure young companies have cash to get them to the point where they...; Tags: Trader, Biotechnology Company, Seeking Alpha, Trader Mark, Biotechnology, Sequenom Inc., Biotech; External links 2008-10-30

Additional Resources

Roanoke Valley, Va., Firm to Be Named Biotechnology Company of Year.: By Jeff Sturgeon, The Roanoke Times, Va. Knight Ridder/Tribune Business News Oct. 14--A Roanoke Valley company tonight will be hoisted onto the collective shoulders of the state's biotechnology industry. Novozymes Biologicals, a Roanoke Valley-based provider of microbe-based products, will ...; Tags: The Roanoke Times; Research articles 2003-10-14
Palm Beach County--Seattle, Wash.-based NeoRx Corp., a cancer therapeutics development company, has become the first biotechnology company to enter into a research alliance with Scripps Florida.(BUSINESS BRIEFS): PALM BEACH COUNTY -- Seattle, Wash.-based NeoRx Corp., a cancer therapeutics development company, has become the first biotechnology company to enter into a research alliance with Scripps Florida. NeoRx will provide $2.5 million over 26 months to sup PALM BEACH COUNTY -- Seattle, Wash.-based NeoRx Corp.,...; Tags: alliance, biotechnology, Palm Beach, Palm Inc.; Research articles 2006-01-01
ZymoGenetics lists IPO on Nasdaq first biotechnology company to go public in 2002.: M2 PRESSWIRE-1 February 2002-NASDAQ: ZymoGenetics lists IPO on Nasdaq first biotechnology company to go public in 2002 C1994-2002 M2 COMMUNICATIONS LTD RDATE:01022002 New York -- The Nasdaq Stock Market, Inc., today announced that ZymoGenetics (NASDAQ:ZGEN) listed the shares of...; Tags: Biotechnology, IPO, Nasdaq Stock Market Inc.; Research articles 2002-02-01
RiboTargets raises GBP32 million; One of the largest European private equity rounds for a biotechnology company in 2001.: M2 PRESSWIRE-26 September 2001-APAX PARTNERS: RiboTargets raises GBP32 million; One of the largest European private equity rounds for a biotechnology company in 2001 C1994-2001 M2 COMMUNICATIONS LTD RDATE:26092001 Cambridge, UK -- RiboTargets Ltd, the biopharmaceutical company, today announces the completion...; Tags: Biotechnology, Company, director, FINANCE, Investment, investor, J.P. Morgan Chase & Co.; Research articles 2001-09-26
Danish biotechnology company Novozymes A/S acquires Canada's Philom Bios Inc: NORDIC BUSINESS REPORT-1 November 2007-Danish biotechnology company Novozymes A/S acquires Canada's Philom Bios IncC1994-2007 M2 COMMUNICATIONS LTD http://www.m2.com Danish biotechnology company Novozymes A/S said on Wednesday (31 October) that its wholly-owned subsidiary, Novozymes Biologicals Holding A/S, has made a cash offer for all shares of the Canadian company Philom...; Tags: Novozymes A/S; Research articles 2007-11-01
Swedish biotechnology company BioGaia AB signs new distribution agreement with Sunstar Suisse SA: NORDIC BUSINESS REPORT-7 January 2008-Swedish biotechnology company BioGaia AB signs new distribution agreement with Sunstar Suisse SAC1994-2008 M2 COMMUNICATIONS LTD http://www.m2.com Swedish biotechnology company BioGaia AB said on Monday (7 January) that it has signed an exclusive distribution agreement with the Swiss company Sunstar Suisse SA. The agreement...; Tags: Sunstar Inc.; Research articles 2008-01-07
Dutch biotechnology company Crucell NV acquires Swedish vaccines maker SBL Vaccin AB: NORDIC BUSINESS REPORT-21 November 2006-Dutch biotechnology company Crucell NV acquires Swedish vaccines maker SBL Vaccin ABC1994-2006 M2 COMMUNICATIONS LTD http://www.m2.com Dutch biotechnology company Crucell NV (Euronext, NASDAQ: CRXL) said on Tuesday (21 November) that it has agreed to acquire Swedish vacccines producer SBL Vaccin AB in a EUR39.4m cash...; Tags: Crucell N.V.; Research articles 2006-11-21
Swedish biotechnology company BioGaia AB expands distribution agreement with Sunstar Suisse SA: NORDIC BUSINESS REPORT-20 September 2007-Swedish biotechnology company BioGaia AB expands distribution agreement with Sunstar Suisse SAC1994-2007 M2 COMMUNICATIONS LTD http://www.m2.com Swedish biotechnology company BioGaia AB said on Thursday (20 September) that it has expanded its distribution agreement with the Swiss-based international oral health products distributor Sunstar Suisse SA. ...; Tags: Sunstar Inc.; Research articles 2007-09-20
Encorium Group, Inc. Announces $1.7 Million Contract With Japanese Biotechnology Company For Phase 2 Clinical Trial For Major Depressive Disorder: WAYNE, Pa. -- Encorium Group, Inc. (Nasdaq:ENCO), a leader in the design, development, and management of complex clinical trials and patient registries for many of the world's leading pharmaceutical and biotechnology companies, today announced the signing of a $1.7 million contract with a Japanese biotechnology company for a Phase 2...; Research articles 2007-07-12